Ambulatory blood pressure in hypertensive patients with inclusion criteria for the SPRINT trial

Journal of the American Society of Hypertension

Volumn 10, Issue 12, 2016, Pages 947-953.e5

  de la Sierra, Alejandro ^a   Banegas, José R ^b   Divisón, Juan A ^c   Gorostidi, Manuel ^d   Vinyoles, Ernest ^a   de la Cruz, Juan J ^b   Segura, Julián ^e   Ruilope, Luis M ^e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Primary Care Center   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Ambulatory blood pressure monitoring; antihypertensive treatment; blood pressure control; white coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); FEMALE; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT SELECTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD PRESSURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; PROCEDURES; REGISTER; RISK FACTOR; SPAIN;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT SELECTION; REGISTRIES; RISK FACTORS; SPAIN;

EID: 85006164508     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.10.013     Document Type: Article

References (18)

1. 1 SPRINT Research Group, Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
2. 2 Jones, D.W., Weatherly, L., Hall, J.E., SPRINT: what remains unanswered and where do we go from here?. Hypertension 67 (2016), 261–262.
3. 3 Touyz, R.M., Dominiczak, A.F., Successes of SPRINT, but still some hurdles to cross. Hypertension 67 (2016), 268–269.
4. 4 Perkovic, V., Rodgers, A., Redefining blood-pressure targets–SPRINT starts the marathon. N Engl J Med 373 (2015), 2175–2178.
5. 5 Bress, A.P., Tanner, R.M., Hess, R., Colantonio, L.D., Shimbo, D., Muntner, P., Generalizability of SPRINT results to the U.S. adult population. J Am Coll Cardiol 67 (2016), 463–472.
6. 6 Cushman, W.C., Whelton, P.K., Fine, L.J., Wright, J.T. Jr., Reboussin, D.M., Johnson, K.C., et al., for the SPRINT Study Research Group. SPRINT trial results: latest news in hypertension management. Hypertension 67 (2016), 263–265.
7. 7 Myers, M.G., Godwin, M., Dawes, M., Kiss, A., Tobe, S.W., Kaczorowski, J., Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension 55 (2010), 195–200.
8. 8 Piper, M.A., Evans, C.V., Burda, B.U., Margolis, K.L., O'Connor, E., Whitlock, E.P., Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 162 (2015), 192–204.
9. 9 O'Brien, E., Parati, G., Stergiou, G., Asmar, R., Beilin, L., Bilo, G., et al., on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31 (2013), 1731–1768.
10. 10 Gorostidi, M., Vinyoles, E., Banegas, J.R., de la Sierra, A., Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res 38 (2015), 1–7.
11. 11 De la Sierra, A., Segura, J., Banegas, J.R., Gorostidi, M., de la Cruz, J.J., Armario, P., et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57 (2011), 898–902.
12. 12 Vinyoles, E., Felip, A., Pujol, E., de la Sierra, A., Durà, R., del Rey, R.H., et al., on behalf of the Spanish Society of Hypertension ABPM Registry. Clinical characteristics of isolated clinic hypertension. J Hypertens 26 (2008), 438–445.
13. 13 De la Sierra, A., Redon, J., Banegas, J.R., Segura, J., Parati, G., Gorostidi, M., et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 53 (2009), 466–472.
14. 14 Banegas, J.R., Ruilope, L.M., de la Sierra, A., de la Cruz, J.J., Gorostidi, M., Segura, J., et al. High prevalence of masked uncontrolled hypertension (MUCH) in people with treated hypertension. Eur Heart J 35 (2014), 3304–3312.
15. 15 Guidelines Committee. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 (2003), 1011–1053.
16. 16 D'Agostino, R.B. Sr., Vasan, R.S., Pencina, M.J., Wolf, P.A., Cobain, M., Massaro, J.M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117 (2008), 743–753.
17. 17 Kjeldsen, S.E., Lund-Johansen, P., Nilsson, P.M., Mancia, G., Unattended blood pressure measurements in the Systolic Blood Pressure Intervention Trial: implications for entry and achieved blood pressure values compared with other trials. Hypertension 67 (2016), 808–812.
18. 18 Drawz, P., Rahman, M., Effect of intensive versus standard clinic-based blood pressure management on ambulatory blood pressure. Results from the SPRINT ABPM study. J Am Soc Hypertens, 10(4S), 2016, e3.